Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv)
Academic Article
Publication Date:
2023
Short description:
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) / Orsi, G., Cavaliere, A., Tortora, G., Lonardi, S., Macchini, M., Di Marco, M., Giordano, G., Vasile, E., Scartozzi, M., Bozzarelli, S., Noventa, S., Rodriquenz, M.G., Militello, A.M., Rapposelli, I.G., Garajova, I., De Lorenzo, S., Merelli, B., Bittoni, A., Salvatore, L., Procaccio, L., et al.. - In: BRITISH JOURNAL OF CANCER. - ISSN 0007-0920. - 128:5(2023), pp. 877-885. [10.1038/s41416-022-02086-w]
abstract:
Pancreatic ductal adenocarcinoma (PDAC) harbouring germline BRCA1-2 pathogenic variants (gBRCA1-2pv) is a distinct nosological entity. Information on second-line therapy (2LT) outcome in this setting is lacking.
Iris type:
1.1 Articolo in rivista
List of contributors:
Orsi, Giulia; Cavaliere, Alessandro; Tortora, Giampaolo; Lonardi, Sara; Macchini, Marina; Di Marco, Mariacristina; Giordano, Guido; Vasile, Enrico; Scartozzi, Mario; Bozzarelli, Silvia; Noventa, Silvia; Rodriquenz, Maria Grazia; Militello, Anna Maria; Rapposelli, Ilario Giovanni; Garajova, Ingrid; De Lorenzo, Stefania; Merelli, Barbara; Bittoni, Alessandro; Salvatore, Lisa; Procaccio, Letizia; Paratore, Chiara; Spallanzani, Andrea; Peretti, Umberto; Niger, Monica; Giommoni, Elisa; Bernardini, Ilaria; Tamburini, Emiliano; Bernardino, Katia; Forti, Laura; Valente, Maria Maddalena; Cascinu, Stefano; Milella, Michele; Reni, Michele
Published in: